Official Journal of Research Center for Gastroenterology and Liver Diseases
OpenAlex
Works that cite this article, indexed by OpenAlex.
Advances in the early diagnosis of hepatocellular carcinoma
Genes & Diseases 7(3) (2020)
Weiyi Wang; Chao Wei
The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis
PLoS ONE 15(2) (2020)
Jiaxin Zhang; Guang Chen; Peng Zhang; Jiaying Zhang; Xiaoke Li; Danan Gan; Xu Cao; Mei Han; Hongbo Du; Yongan Ye
Effectiveness of PIVKA-II in the detection of hepatocellular carcinoma based on real-world clinical data
BMC Cancer 17(1) (2017)
Rentao Yu; Zhaoxia Tan; Xiaomei Xiang; Yunjie Dan; Guohong Deng
Direct comparison of five serum biomarkers in early diagnosis of hepatocellular carcinoma
Cancer Management and Research Volume 10 (2018)
Hongda Chen; Yue Zhang; Siwen Li; Ni Li; Yuhan Chen; Bei Zhang; Chunfeng Qu; Huiguo Ding; Jian Huang; Min Dai
Protein induced by vitamin K absence or antagonist-II versus alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: A systematic review with meta-analysis
Hepatobiliary & pancreatic diseases international 17(6) (2018)
Hao Xing; Yijie Zheng; Jun Shu Han; Han Zhang; Zhenli Li; W. Y. Lau; Feng Shen; Tian Yang
Performance of protein induced by vitamin K absence or antagonist-II assessed by chemiluminescence enzyme immunoassay for hepatocellular carcinoma detection: a meta-analysis
Scandinavian Journal of Gastroenterology 53(6) (2018)
Gian Paolo Caviglia; Davide Giuseppe Ribaldone; Maria Lorena Abate; Alessia Ciancio; Rinaldo Pellicano; Antonina Smedile; Giorgio Maria Saracco
Combining des-gamma-carboxyprothrombin and alpha-fetoprotein for hepatocellular carcinoma diagnosing: an update meta-analysis and validation study
Oncotarget 8(52) (2017)
Huaping Chen; Siyuan Chen; Shan Li; Zhijian Chen; Xuan Zhu; Meiyu Dai; Lingxi Kong; Xiaodan Lv; Zhili Huang; Xue Ying Qin
Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma
World Journal of Gastroenterology 22(37) (2016)
Stijn Van Hees; Peter P. Michielsen; Thomas Vanwolleghem
PIVKA-II as a Potential New Biomarker for Hepatocellular Carcinoma – A Pilot Study
In Vivo 32(6) (2018)
Šárka Svobodová; Marie Karlíková; Ondřej Topolčan; Ladislav Pecen; Martina Peštová; OTTO KOTT; Vladislav Třeška; David Slouka; Radek Kučera
Diagnostic value of prothrombin induced by the absence of vitamin K or antagonist-II (PIVKA-II) for early stage HBV related hepatocellular carcinoma
Infectious Agents and Cancer 12(1) (2017)
Xiumei Wang; Weiwei Zhang; Youde Liu; Wenjing Gong; Ping Sun; Xiangshuo Kong; Miaomiao Yang; Zhihua Wang
Diagnosis of the Initial Stage of Hepatocellular Carcinoma: A Review
Current Pharmaceutical Design 30(22) (2024)
Krishna Kumar Sharma; Mohd. Mohsin; Piyush Mittal; Zeeshan Ali; Nishat Fatma; Prashant Upadhyay; Ritu Gupta; Anurag Kumar Verma; Gajendra Kumar
Protein Induced by Vitamin K Absence or Antagonist-II Versus Alpha-Fetoprotein in the Diagnosis of Hepatocellular Carcinoma: A Systematic Review With Meta-Analysis
Journal of Clinical Medicine Research 15(7) (2023)
Abdallah A. Kobeissy; Nooraldin Merza; Alsadiq Al‐Hillan; Safa Boujemaa; Zohaib Ahmed; Mohamad Nawras; Mohammed Albaaj; Dushyant Singh Dahiya; Yaseen Alastal; Mona Mamdouh Hassan
Efficacy of PIVKA-II in prediction and early detection of hepatocellular carcinoma: a nested case-control study in Chinese patients
Scientific Reports 6(1) (2016)
Rentao Yu; Xiaomei Xiang; Zhaoxia Tan; Yi Zhou; Haoliang Wang; Guohong Deng
Biomarkers vs imaging in the early detection of hepatocellular carcinoma and prognosis
World Journal of Clinical Cases 7(12) (2019)
Lavinia Alice Bălăceanu
Evaluation of the diagnostic accuracy of des-gamma-carboxy prothrombin and alpha-fetoprotein alone or in combination for hepatocellular carcinoma: A systematic review and meta-analysis
Surgical Oncology 34 (2020)
Jia Fan; Yu Chen; Dan Zhang; Juan Yao; Zijun Zhao; Yao Jiang; Yiqin Li; Yongcan Guo
Eag1 channels as potential early-stage biomarkers of hepatocellular carcinoma
Biologics Volume 10 (2016)
Javier Camacho; María de Guadalupe Chávez-López; Violeta Zúñiga-García; Julio Isael Pérez‐Carreón; Arturo Ávalos‐Fuentes; Yesenia Escobar
Simple and robust diagnosis of early, small and AFP-negative primary hepatic carcinomas: an integrative approach of serum fluorescence and conventional blood tests
Oncotarget 7(39) (2016)
Ting Wang; Kun-He Zhang; Piao-Ping Hu; Zeng-Yong Huang; Pan Zhang; Qin-Si Wan; Deqiang Huang; Nonghua Lv
DNA Methylation Biomarkers as Prediction Tools for Therapeutic Response and Prognosis in Intermediate-Stage Hepatocellular Carcinoma
Cancers 15(18) (2023)
Chang-Yi Lu; Chih‐Yang Hsiao; Pey-Jey Peng; Shao-Chang Huang; Meng‐Rong Chuang; Hung-Ju Su; Kai‐Wen Huang
Characterization of Gla proteoforms and non-Gla peptides of gamma carboxylated proteins: Application to quantification of prothrombin proteoforms in human plasma
Analytica Chimica Acta 1284 (2023)
Dilip Kumar Singh; Abdul Basit; Allan E. Rettie; Nathan Alade; Kenneth E. Thummel; Bhagwat Prasad
PIVKA-II combined with alpha-fetoprotein for the diagnostic value of hepatic tumors in children: a multicenter, prospective observational study
Hepatology International 18(4) (2024)
Hongxiang Gao; Chenjie Xie; Jing Wang; Ji Ma; Shijian Liu; Li Hui Xie; Yijie Zheng; Rui Dong; Shan Wang; Yongjun Fang; Yurui Wu; Xianwei Zhang; Xianying Lu; Yang Li; Weisong Li; Qiuhui Pan; Min Xu; Song Gu
A Novel LC‐MS/MS Assay for Quantification of Des‐carboxy Prothrombin and Characterization of Warfarin‐Induced Changes
Clinical and Translational Science 13(4) (2020)
Abdul Basit; Bhagwat Prasad; Joanne K. Estergreen; Daniel E. Sabath; Nathan Alade; David Leroy Veenstra; Allan E. Rettie; Kenneth E. Thummel
Combination of serum alpha-fetoprotein, PIVKA-Ⅱ and glypican-3 in diagnosis of hepatocellular carcinoma: a meta-analysis
Journal of Zhejiang University (Medical Sciences) 53(1) (2024)
Hongliang SONG; Jianguo WANG; Hui ZHANG; Yongfeng WU; Kai Wang; Xiaobo Wang; Xiao Xu
Optimizing care of HBV infection and HBV-related HCC
Clinical Liver Disease 23(1) (2024)
Shi Yan Lee; Benjamin Kai Yi Nah; Jazleen Leo; Jia Hong Koh; Daniel Q. Huang
Combining serologic biomarkers with the PAGE B score improves risk stratification for hepatocellular carcinoma development among chronic hepatitis B patients
Scientific Reports 15(1) (2025)
Michael Stec; Mark G. Anderson; Mary A. Rodgers; Tiffany Fortney; Danny K.-H. Wong; Lung‐Yi Mak; Man‐Fung Yuen; Gavin Cloherty
A novel model based on interleukin 6 and insulin-like growth factor II for detection of hepatocellular carcinoma associated with hepatitis C virus
Journal of Genetic Engineering and Biotechnology 19(1) (2021)
Mohamed M. Omran; Sara Mosaad; Tarek Mostafa Emran; Fathy Mohamad Abdel Aziz El‐Taweel; Khaled Farid
New Thresholds for AFP and Des-γ-Carboxy Prothrombin in Chronic Liver Disease Depending on the Use of Nucleoside Analogs and an Integrated Nomogram
International Journal of General Medicine Volume 14 (2021)
Ting Sun; Ruicen Li; Yiwen Qiu; Shu Yi Shen; Wentao Wang
Levels of PIVKA-II and alpha-fetoprotein in unresectable hepatocellular carcinoma compared to healthy controls and predictive values of both markers with radiological responses after loco-regional interventions
PeerJ 11 (2023)
Norhanan Hamzah; Nur Karyatee Kassim; Julia Omar; Mohd Shafie Abdullah; Yeong Yeh Lee
The role of PIVKA-II in hepatocellular carcinoma surveillance in an Asian population
Annals of the Academy of Medicine Singapore 52(2) (2023)
Wai-Yoong Ng; Daniel Yan Zheng Lim; Si-Yu Tan; Jason Pik‐Eu Chang; Thinesh Lee Krishnamoorthy; Chee-Hooi Lim; Damien Meng Yew Tan; Victoria Sze Min Ekstrom; George Boon‐Bee Goh; Mark Chang Chuen Cheah; Rajneesh Kumar; Chin‐Pin Yeo; Chee‐Kiat Tan
Diagnostic value of TAP, PIVKA-II, and AFP in hepatocellular carcinoma and their prognostic value for patients treated with transarterial chemoembolization
Laboratory Medicine 56(3) (2025)
Delu Gan; Yali Wang; Xin Yang; Juan Huang; Lijun Zhang; Bianqin Guo; Pu Li; Dan Gou